[1]
M. Giavina-Bianchi, L. Vicente Rizzo, and P. Giavina-Bianchi, “Severe atopic dermatitis: Dupilumab is not just safer, but more efficient”, Allergol Immunopathol, vol. 48, no. 6, pp. 792–797, Dec. 2020, Accessed: Sep. 30, 2025. [Online]. Available: https://all-imm.com/index.php/aei/article/view/114